![Bryan Giraudo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Giraudo
Finanzdirektor/CFO bei
GOSSAMER BIO, INC.
Vermögen: 6 Mio $ am 31.07.2026
Profil
Bryan Giraudo is currently an Independent Director at Valerio Therapeutics SA since 2021, an Independent Director at Protagonist Therapeutics, Inc. since 2018, and Chief Financial & Operating Officer at Gossamer Bio, Inc. since 2021.
Former positions include Senior Managing Director at Leerink Partners LLC from 2009 to 2018, Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, and Managing Director at Pierce Fenner & Smith, Inc. Education includes an undergraduate degree from Georgetown University conferred in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.05.2026 | 40’520 ( 0.06% ) | 6 Mio $ | 31.07.2026 | |
GOSSAMER BIO, INC. 0.12% | 20.04.2026 | 572’747 ( 0.12% ) | 96 794 $ | 31.07.2026 |
Aktive Positionen von Bryan Giraudo
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.05.2018 |
| GOSSAMER BIO, INC. | Finanzdirektor/CFO | 07.05.2018 |
| VALERIO THERAPEUTICS | Direktor/Vorstandsmitglied | 23.11.2021 |
Ehemalige bekannte Positionen von Bryan Giraudo
| Unternehmen | Position | Ende |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01.05.2018 |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01.07.2009 |
Pierce Fenner & Smith, Inc.
 Pierce Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Corporate Officer/Principal | - |
Ausbildung von Bryan Giraudo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Pierce Fenner & Smith, Inc.
Pierce Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Merrill Lynch & Co., Inc.
Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
